Shanghai Pharmaceuticals Holding Co., Ltd. - Net Worth and Insider Trading

Shanghai Pharmaceuticals Holding Co., Ltd. Net Worth

The estimated net worth of Shanghai Pharmaceuticals Holding Co., Ltd. is at least $217 Million dollars as of 2025-06-09. Shanghai Pharmaceuticals Holding Co., Ltd. is the of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd and owns about 70,564,000 shares of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKSE:01349) stock worth over $217 Million. Details can be seen in Shanghai Pharmaceuticals Holding Co., Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Shanghai Pharmaceuticals Holding Co., Ltd. has not made any transactions after 2022-06-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Shanghai Pharmaceuticals Holding Co., Ltd.

Shanghai Pharmaceuticals Holding Co., Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Shanghai Pharmaceuticals Holding Co., Ltd. owns 1 companies in total, including Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKSE:01349) .

Click here to see the complete history of Shanghai Pharmaceuticals Holding Co., Ltd.’s form 4 insider trades.

Insider Ownership Summary of Shanghai Pharmaceuticals Holding Co., Ltd.

Ticker	Company	Transaction Date	Type of Owner
HKSE:01349	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd	2022-06-07

Shanghai Pharmaceuticals Holding Co., Ltd. Latest Holdings Summary

Shanghai Pharmaceuticals Holding Co., Ltd. currently owns a total of 1 stock. Shanghai Pharmaceuticals Holding Co., Ltd. owns 70,564,000 shares of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKSE:01349) as of June 7, 2022, with a value of $217 Million.

Latest Holdings of Shanghai Pharmaceuticals Holding Co., Ltd.

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:01349	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd	2022-06-07	70,564,000	3.08	217,337,120

Holding Weightings of Shanghai Pharmaceuticals Holding Co., Ltd.

Shanghai Pharmaceuticals Holding Co., Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, Shanghai Pharmaceuticals Holding Co., Ltd. has made a total of 1 transactions in Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKSE:01349) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is the sale of 0 shares on June 7, 2022, which brought Shanghai Pharmaceuticals Holding Co., Ltd. around $0.

Insider Trading History of Shanghai Pharmaceuticals Holding Co., Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Shanghai Pharmaceuticals Holding Co., Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Shanghai Pharmaceuticals Holding Co., Ltd. Ownership Network

Ownership Network List of Shanghai Pharmaceuticals Holding Co., Ltd.

No Data

Ownership Network Relation of Shanghai Pharmaceuticals Holding Co., Ltd.

Shanghai Pharmaceuticals Holding Co., Ltd. Owned Company Details

What does Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd do?

Who are the key executives at Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd?

Shanghai Pharmaceuticals Holding Co., Ltd. is the of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd. Other key executives at Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd include and 2102 Investment manager Invesco Hong Kong Limited .

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKSE:01349) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKSE:01349) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKSE:01349) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKSE:01349)'s detailed insider trading history can be found in Insider Trading Tracker table.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Insider Transactions

No Available Data

Shanghai Pharmaceuticals Holding Co., Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Shanghai Pharmaceuticals Holding Co., Ltd.. Currently GuruFocus does not have mailing address information for Shanghai Pharmaceuticals Holding Co., Ltd..

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.